Summary of the 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: Prepared by the Czech Society of Cardiology
2012
Abstract
Guidelines summarise and evaluate all currently available evidence on a particular issue with the aim of assisting physicians in selecting the best management strategy for an individual patient suffering from a given condition. Since August 2010, when ESC guidelines for the management of atrial fibrillation (AF) were published, European regulatory approvals of several new drugs were announced, reports from major clinical trials of the novel oral anticoagulants revealed, and one antiarrhythmic drug study was early discontinuated.
Therefore, an update of the ESC guidelines was prepared. It is not intended as a comprehensive new guideline.
This article is the summary of an update to the 2010 ESC Guidelines.